Genetic Inclusion by Virtual Evaluation
Part of paid clinical trials in Edinburg, Texas.
- Sponsor
- Baylor College of Medicine
- Study ID
- NCT05318222
- Status
- Recruiting
Conditions
- Birth Defects
- Multiple Congenital Anomaly
- Neurodevelopmental Disorders
Eligibility Criteria
- Sex
- ALL
- Age
- 1 Day - 18 Years
- Healthy Volunteers
- Accepted
Interventions
- Whole genome sequencing (WGS) — DIAGNOSTIC_TESTWGS will identify copy number variations (CNVs), single nucleotide variants (SNVs), as well as triplet repeat disorders in children with rare diseases
Study Details
This study aims to transform the current clinical practice paradigm by leveraging an internally designed web-based model of delivery of care called Consultagene to provide remote evaluation and genomic sequencing for improving genetic health of less resourced children with rare disorders living along the Texas-Mexico border.
Key Dates
- Start date
- Jun 1, 2022
- Status verified
- Jan 2025
- Primary completion
- Jan 31, 2027
- Completion
- Jan 31, 2027
Study Design
- Enrollment
- 200 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Other: WGS armAll 200 patients recruited will undergo WGS
Primary Outcome Measure
Time to diagnosis [ Time Frame: 12 months ]
Central Contacts
- Seema Lalani, MD832-822-4280
- Brendan Lee, MD; PhD832-822-4280
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Texas Rio Grande Valley | Edinburg | Texas | 78539 | Lori Berry, MD |
Find similar trials in Edinburg, TX
By research site
Related Studies
- Rett Syndrome RegistryRecruiting · International Rett Syndrome Foundation · Birmingham, Alabama
- Word Learning From Parentese in Autistic ChildrenRecruiting · The University of Texas at Dallas · Richardson, Texas
- Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal DisordersRecruiting · Healing Hope International · The Woodlands, Texas
- Intranasal Insulin for Autism Spectrum Disorder in Children and Young Adults Aged 4 to 21 YearsEnrolling By Invitation · Healing Hope International · Spring, Texas